🔎 Trials Near Me

Dachaigh › Leukemia biphenotypic geur › California › Los Angeles

Sgrùdaidhean clionaigeach Leukemia biphenotypic geur ann an Los Angeles, CA

Tha 6 sgrùdaidhean airson Leukemia biphenotypic geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Los Angeles (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

A’ fastadhÌre 3
  • Children's Hospital Los Angeles, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
365 Days – 25 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT03959085

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

A’ fastadhÌre 1/2
  • Valkyrie Clinical Trials, Los Angeles
Aoisean 13 gu 90 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06533579

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

A’ fastadhÌre 2
  • UCLA Department of Medicine, Los Angeles
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07216443

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

A’ fastadhÌre 1/2
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
Aoisean 12 gu 95 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

A’ fastadhÌre 1
  • Children's Hospital Los Angeles, Los Angeles
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Dùbh 2024 · NCT05476770

Sgrùdaidhean Leukemia biphenotypic geur ann am bailtean eile

Sgrùdaidhean eile ann an Los Angeles

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.